• Journal Article

Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy.

Citation

Harrison, C., Mesa, R., Kiladjian, J-J., Al-Ali, H-K., Knoops, L., Squier, M., & Copley-Merriman, C. (2013). Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy. British Journal of Haematology, 162(2), 229 - 39.

Abstract